Drawing for LLAMDA

USPTO serial 79175835

LLAMDA

Reviewed by CopyMark Law Group

Reg. 5051793Status 404
Filing date
Status date
Registration date
Oct 4, 2016
Examiner
MARESCA, MEREDITH Z
Law office
Historical data usage

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LLAMDA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven M. Espenshade

Steven M. Espenshade Pirkey Barber PLLC1801 East 6th StreetSuite 300Austin, TX 78702

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic and therapeutic synthetic peptides, proteins, molecules, antibodies, polypeptides and polymers for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biochemical and biological substances for medical diagnostics and analysis, namely, pharmaceutical preparations and substances for the diagnosis and analytics of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disordersSECTION 71 - CANCELLED—
042Scientific, pharmaceutical, medical, biological, biochemical, biotechnology and medical diagnostic research; biochemical and biotechnological engineering; biochemical engineering of peptides, proteins, molecules, antibodies, polypeptides and polymersSECTION 71 - CANCELLED—
045Licensing of intellectual property rights and of technology in the field of in-vitro screening and protein engineering; licensing of technology relating to discovery of peptides for therapeutic and non-therapeutic applicationsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 19, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 19, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 27, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 30, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 29, 2025INPCINVALIDATION PROCESSED—
May 7, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 7, 2024NC71NOTICE OF CANCELLATION SEC. 71 E-MAILED—
Sep 7, 2024C71TCANCELLED SECTION 71—
Feb 22, 2024PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Nov 6, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 31, 2023ES75TEAS SECTION 71 & 15 RECEIVED—
Oct 4, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 13, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 9, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 3, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 10, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 10, 2017FIMPFINAL DISPOSITION PROCESSED—
Jan 4, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 4, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 19, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 19, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 29, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 29, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 13, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 4, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 1, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 1, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2016ALIEASSIGNED TO LIE—
May 17, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 4, 2015RFNTREFUSAL PROCESSED BY IB—
Nov 17, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 17, 2015RFRRREFUSAL PROCESSED BY MPU—
Nov 17, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 14, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 13, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2015DOCKASSIGNED TO EXAMINER—
Nov 12, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 7, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance